Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1365
https://www.valueinhealthjournal.com/article/S1098-3015(16)32731-0/fulltext
Title : Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32731-0&doi=10.1016/j.jval.2016.09.1365
First page : A583
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1283
Categories :
Tags :
Regions :
ViH Article Tags :